LIBRETTO-001 cohort 7: A single-arm, phase 2 study of neoadjuvant selpercatinib in patients with resectable stage IB-IIIA RET fusion-positive NSCLC.

被引：0

作者：

Rajaram, Ravi

Sholl, Lynette M.

Dacic, Sanja

Goldman, Jonathan W.

Tan, Daniel Shao-Weng

Gautschi, Oliver

Loong, Herbert H. F.

De Braud, Filippo G.

Massarelli, Erminia

Levy, Benjamin Philip

Dy, Grace K.

Kang, Suhyun

Szymczak, Sylwia

Chao, Bo H.

Drilon, Alexander E.

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX USA

[2] Brigham & Womens Hosp, Dept Pathol, Boston, MA USA

[3] Harvard Med Sch, Boston, MA USA

[4] Univ Pittsburgh, Dept Pathol, Med Ctr, Pittsburgh, PA USA

[5] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA

[6] Duke NUS Med Sch, Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore

[7] Univ Bern, Luzern, Switzerland

[8] Cantonal Hosp Lucerne, Luzern, Switzerland

[9] Chinese Univ Hong Kong, Hong Kong, Peoples R China

[10] Univ Milan, ENETS Ctr Excellence, Fdn IRCCS Ist Tumori Milano, Oncol & Hemato Oncol Dept,Dept Med Oncol, Milan, Italy

[11] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA USA

[12] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Baltimore, MD USA

[13] Roswell Pk Comprehens Canc Ctr, Dept Med, Buffalo, NY USA

[14] Eli Lilly & Co, Indianapolis, IN USA

[15] Eli Lilly Polska, Warsaw, Poland

[16] Eli Lilly & Co, New York, NY USA

[17] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA

[18] Weill Cornell Med Coll, New York, NY USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS8594

引用

页数：1